XML 14 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 406,665 $ 9 $ 853,824 $ (626,456) $ (11,094)   $ 622,948
Beginning balance, shares at Dec. 31, 2020 23,219,613 92,490,768   (800,000)        
Exercise of stock options 776   776
Exercise of stock options, shares   1,082,964            
Exercise of common stock warrants 15,803   15,803
Exercise of common stock warrants, shares   536,825            
Stock based compensation 9,374   9,374
Foreign currency translation adjustment              
Net loss attributable to non-controlling interest (76)   (76)
Net loss (70,110)   (70,110)
Conversion of Series AA Preferred Stock $ (406,665) $ 5 406,660  
Conversion of Series AA Preferred Stock, shares (23,219,613) 46,439,226            
Recognition of debt discount on 2026 Convertible Notes $ 88,059   $ 88,059
Issuance of treasury stock in connection with acquisition 8,538,000   8,538,000
Issuance of treasury stock in connection with acquisitions, shares       $ 623,068        
Other $ (5)   $ (5)
Ending balance, shares at Mar. 31, 2021 140,549,783   (176,932)        
Ending balance, value at Mar. 31, 2021 $ 14 1,383,029 (696,566) (11,170)   675,307
Beginning balance, value at Dec. 31, 2021 $ 16 1,691,206 (1,009,293) (11,220) $ 172 670,881
Beginning balance, shares at Dec. 31, 2021 153,950,895            
Issuance of common stock/At-the-market offering, net of offering costs   $ 2 203,794   203,796
Issuance of common stock/At-the-market offering, net of offering costs, shares   27,443,580            
Reclassification of the equity components of the 2026 Convertible Notes to liability upon adoption of ASU 2020-06   (87,946)   12,682 (75,264)
Exercise of stock options   443   $ 443
Exercise of stock options, shares   349,847           349,847
Exercise of common stock warrants   10,249   $ 10,249
Exercise of common stock warrants, shares   540,541            
Delivery of common stock underlying restricted stock units
Delivery of common stock underlying restricted stock units, shares 392,326          
Stock based compensation   19,449   19,449
Foreign currency translation adjustment     (2,215) (2,215)
Net loss attributable to non-controlling interest     (93) (93)
Net loss     (140,724) (140,724)
Ending balance, shares at Mar. 31, 2022 182,677,189          
Ending balance, value at Mar. 31, 2022 $ 18 $ 1,837,195 $ (1,137,335) $ (11,313) $ (2,043) $ 686,522